LY3819469

Eli Lilly Collab Scores IND Approval for Dicerna's RNAi Cardiometabolic Drug
BioSpace
Thu, 05/27/21 - 11:09 am
Dicerna
Eli Lilly
LY3819469
clinical trials
RNAi
cardiometabolic diseases